In pharmaceutical industry, L-phenylacetylcarbinol (L-PAC) is used as
an intermediate for the production of L-ephedrine hydrochloride--a wel
l known bronchodilator. Certain yeast strains are known to transform b
enzaldehyde to produce L-PAC with the help of a specific enzyme pyruva
te decarboxylase (PDC) and pyruvate. Simultaneously another by-product
, benzyl alcohol is also produced by another enzyme alcohol dehydrogen
ase (ADH). Strains belonging to the genera Saccharomyces and Candida h
ave been found to be more efficient L-PAC producers as comparison to o
ther yeasts. The formation of L-PAC is determined by the growth and bi
otransformation conditions. In the presence of benzaldehyde, cell grow
th is adversely affected and L-PAC production is low. Harvested whole
cells immobilized in different carriers have shown tolerance for highe
r benzaldehyde doses and increased L-PAC yield has been obtained with
semicontinuous mode of benzaldehyde biotransformation. Strain improvem
ent also has effectively enhanced the yield of L-PAC. Studies with iso
lated PDC enzyme have shown significant potential for improving the L-
PAC yield.